Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	BCL9L MED18 RBBP8 PHF12 NSD1 NFKBIZ ACTN4 PHF8 CREBBP CEBPZ TLE1 SCAI	4.36e-05	562	106	12	GO:0003712
Domain	CH	GAS2L3 ACTN4 MACF1 CNN1 VAV2	3.69e-05	65	108	5	SM00033
Domain	CH	GAS2L3 ACTN4 MACF1 CNN1 VAV2	5.29e-05	70	108	5	PF00307
Domain	-	GAS2L3 ACTN4 MACF1 CNN1 VAV2	5.66e-05	71	108	5	1.10.418.10
Domain	CH	GAS2L3 ACTN4 MACF1 CNN1 VAV2	6.47e-05	73	108	5	PS50021
Domain	CH-domain	GAS2L3 ACTN4 MACF1 CNN1 VAV2	7.37e-05	75	108	5	IPR001715
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B2	1.97e-04	4	108	2	IPR022141
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B2	1.97e-04	4	108	2	PF12424
Domain	VDCC_L_a1su	CACNA1F CACNA1S	1.97e-04	4	108	2	IPR005446
Domain	P-type_ATPase_IIB	ATP2B1 ATP2B2	1.97e-04	4	108	2	IPR006408
Domain	GAR	GAS2L3 MACF1	4.89e-04	6	108	2	PS51460
Domain	GAS2	GAS2L3 MACF1	4.89e-04	6	108	2	PF02187
Domain	-	GAS2L3 MACF1	4.89e-04	6	108	2	3.30.920.20
Domain	GAS_dom	GAS2L3 MACF1	4.89e-04	6	108	2	IPR003108
Domain	GAS2	GAS2L3 MACF1	4.89e-04	6	108	2	SM00243
Domain	Ca_chan_IQ	CACNA1F CACNA1S	6.83e-04	7	108	2	SM01062
Domain	Ca_chan_IQ	CACNA1F CACNA1S	6.83e-04	7	108	2	PF08763
Domain	VDCC_a1su_IQ	CACNA1F CACNA1S	6.83e-04	7	108	2	IPR014873
Domain	GPHH	CACNA1F CACNA1S	6.83e-04	7	108	2	PF16905
Domain	GPHH_dom	CACNA1F CACNA1S	6.83e-04	7	108	2	IPR031649
Domain	ARM-type_fold	CKAP5 NBEA SCYL2 NF1 CEBPZ XPO6 EFR3B UNC79	7.91e-04	339	108	8	IPR016024
Domain	Serpin_dom	HMSD SERPINB2 SERPIND1	1.17e-03	36	108	3	IPR023796
Domain	SERPIN	HMSD SERPINB2 SERPIND1	1.27e-03	37	108	3	PS00284
Domain	Serpin	HMSD SERPINB2 SERPIND1	1.37e-03	38	108	3	PF00079
Domain	VDCCAlpha1	CACNA1F CACNA1S	1.45e-03	10	108	2	IPR002077
Domain	Serpin_fam	HMSD SERPINB2 SERPIND1	1.48e-03	39	108	3	IPR000215
Domain	ATPase_P-typ_TM_dom	ATP2B1 ATP2B2	3.77e-03	16	108	2	IPR023298
Domain	-	ATP2B1 ATP2B2	3.77e-03	16	108	2	1.20.1110.10
Domain	ATPase_P-typ_cation-transptr_C	ATP2B1 ATP2B2	4.26e-03	17	108	2	IPR006068
Domain	Cation_ATPase_C	ATP2B1 ATP2B2	4.26e-03	17	108	2	PF00689
Domain	Cation_ATPase_N	ATP2B1 ATP2B2	4.77e-03	18	108	2	PF00690
Domain	Cation_ATPase_N	ATP2B1 ATP2B2	4.77e-03	18	108	2	SM00831
Domain	ARM-like	CKAP5 NBEA SCYL2 NF1 XPO6 EFR3B	4.84e-03	270	108	6	IPR011989
Domain	ATPase_P-typ_cation-transptr_N	ATP2B1 ATP2B2	5.31e-03	19	108	2	IPR004014
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GAS2L3 CKAP5 ACTN4 TFG RBM39 SLC3A2 DHX8 TFRC TARDBP IGF2R NF1 UBR5 CEBPZ GNA13 SVIL MACF1 ATP2B1	2.79e-08	1024	111	17	24711643
Pubmed	Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.	KIR2DS2 KIR2DL2 KIR2DL3	3.16e-08	3	111	3	30696053
Pubmed	Trafficking of presynaptic PMCA signaling complexes in mouse photoreceptors requires Cav1.4 α1 subunits.	CACNA1F ATP2B1 ATP2B2	3.16e-08	3	111	3	22183401
Pubmed	Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	3.16e-08	3	111	3	22960345
Pubmed	Imputation of KIR Types from SNP Variation Data.	KIR2DS2 KIR2DL2 KIR2DL3	3.16e-08	3	111	3	26430804
Pubmed	Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.	KIR2DS2 KIR2DL2 KIR2DL3	3.16e-08	3	111	3	18292496
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CKAP5 SRP54 ACTN4 PHF8 CREBBP RBM39 SLC3A2 TFRC TARDBP TBC1D4 NF1 ARAP3 UBR5 CEBPZ MCM3AP ASNS MACF1 ATP2B1 CAPRIN1	5.55e-08	1353	111	19	29467282
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	HIVEP1 ZNF280D ZFYVE16 RBBP8 PHF12 CKAP5 TNRC6B TBC1D4 UBR5 TLE1 ZFHX3	1.07e-07	418	111	11	34709266
Pubmed	KIR/HLA ligand incompatibility in kidney transplantation.	KIR2DS2 KIR2DL2 KIR2DL3	1.26e-07	4	111	3	18091530
Pubmed	Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.	KIR2DS2 KIR2DL2 KIR2DL3	1.26e-07	4	111	3	16929347
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CKAP5 NSD1 ACTN4 RBM39 DHX8 IGF2R NF1 UBR5 CEBPZ MCM3AP ASNS MACF1 CAPRIN1	1.79e-07	653	111	13	22586326
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9L HIVEP1 PHF12 SSBP2 CREBBP EMSY TFRC TLE1 MCM3AP ZFHX3	2.02e-07	351	111	10	38297188
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DS2 KIR2DL2 KIR2DL3	3.15e-07	5	111	3	18755860
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	3.15e-07	5	111	3	16112031
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNRC6B SRP54 ACTN4 VPS13D TBC1D4 UBR5 MACF1 CAPRIN1	3.86e-07	209	111	8	36779422
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	6.28e-07	6	111	3	17882223
Pubmed	Human transcription factor protein interaction networks.	SOX6 BCL9L HIVEP1 PHF12 TNRC6B R3HDM2 SSBP2 PHF8 CREBBP EMSY TFRC TARDBP ERLIN2 TLE1 SVIL ZFHX3 USP27X CAPRIN1	6.34e-07	1429	111	18	35140242
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL2 KIR2DL3	1.10e-06	7	111	3	11169255
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DL2 KIR2DL3	1.75e-06	8	111	3	17200871
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL2 KIR2DL3	1.75e-06	8	111	3	18681957
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	MED18 RBBP8 PHF12 NSD1 CREBBP EMSY SLC3A2 UBR5 ATP2B1 SCAI	2.03e-06	453	111	10	29656893
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CKAP5 NSD1 TNRC6B NBEA SLC1A2 EMSY IGF2R NF1 UBR5 SVIL MACF1 EXOG UNC79 CAPRIN1	2.47e-06	963	111	14	28671696
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9L MED18 HIVEP1 PHF12 SSBP2 CREBBP EMSY TLE1	2.49e-06	268	111	8	33640491
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL2 KIR2DL3	2.62e-06	9	111	3	7749980
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DL3	2.62e-06	9	111	3	8662091
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HIVEP1 ZNF280D CKAP5 ACTN4 TFG RBM39 SLC3A2 DHX8 TFRC TARDBP ERLIN2 IGF2R NF1 CEBPZ ASNS ATP2B1 CAPRIN1	2.80e-06	1425	111	17	30948266
Pubmed	LZTR1 is a regulator of RAS ubiquitination and signaling.	SLC4A7 SLC3A2 TFRC IGF2R NF1 ATP2B1	3.48e-06	127	111	6	30442766
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL2 KIR2DL3	3.74e-06	10	111	3	12559621
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	CKAP5 VPS13D TBC1D4 MCM3AP CNTNAP4 MACF1	3.99e-06	130	111	6	12421765
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	SLC4A7 ZFYVE16 TNRC6B GPRC5C TFG SLC3A2 DHX8 TFRC ERLIN2 IGF2R CEBPZ TLE1	4.13e-06	733	111	12	34672954
Pubmed	Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes.	BCL9L CREBBP UBR5 TLE1	4.23e-06	34	111	4	30894540
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL2 KIR2DL3	5.12e-06	11	111	3	18830515
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL2 KIR2DL3	5.12e-06	11	111	3	19664392
Pubmed	FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.	CKAP5 TFG ERLIN2 IGF2R GNA13 ASNS ATP2B1	5.62e-06	212	111	7	33462405
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL2 KIR2DL3	6.82e-06	12	111	3	20371502
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DL2 KIR2DL3	6.82e-06	12	111	3	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DL2 KIR2DL3	6.82e-06	12	111	3	19181658
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	SGTA CKAP5 SRP54 LAMP1 ACTN4 GPRC5C TFG RBM39 EMSY SLC3A2 TFRC TARDBP IGF2R ASNS SCP2 VAV2	7.20e-06	1367	111	16	32687490
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	LAMP1 ACTN4 TFRC TARDBP ERLIN2 IGF2R SVIL ATP2B1	7.60e-06	312	111	8	37120454
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DL2 KIR2DL3	8.84e-06	13	111	3	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DL2 KIR2DL3	8.84e-06	13	111	3	19120281
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DL2 KIR2DL3	8.84e-06	13	111	3	18687225
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	BCL9L CACNA1S ETS2 MACF1 CAPRIN1 DNAH11	9.79e-06	152	111	6	34299191
Pubmed	Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.	KIR2DL2 KIR2DL3	1.01e-05	2	111	2	25359276
Pubmed	Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population.	KIR2DL2 KIR2DL3	1.01e-05	2	111	2	26423800
Pubmed	KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	22836042
Pubmed	Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.	KIR2DL2 KIR2DL3	1.01e-05	2	111	2	33846289
Pubmed	Identification and structural basis for a novel interaction between Vav2 and Arap3.	ARAP3 VAV2	1.01e-05	2	111	2	22750419
Pubmed	Expression of KIR2DL3 and KIR2DS2 natural killer receptors in exercise.	KIR2DS2 KIR2DL3	1.01e-05	2	111	2	21165439
Pubmed	Identification of four novel KIR2DL2 alleles and two novel KIR2DL3 alleles in an East African population.	KIR2DL2 KIR2DL3	1.01e-05	2	111	2	20875478
Pubmed	Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	32961633
Pubmed	KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	27251940
Pubmed	Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.	KIR2DL2 KIR2DL3	1.01e-05	2	111	2	15248031
Pubmed	High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	24122895
Pubmed	Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.	KIR2DL2 KIR2DL3	1.01e-05	2	111	2	23686481
Pubmed	KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles.	KIR2DL2 KIR2DL3	1.01e-05	2	111	2	27030405
Pubmed	The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes.	KIR2DS2 KIR2DL3	1.01e-05	2	111	2	9497500
Pubmed	Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	35154153
Pubmed	Killer cell immunoglobulin receptor profile on CD4(+) CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients.	KIR2DS2 KIR2DL3	1.01e-05	2	111	2	25484131
Pubmed	Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes.	DLEC1 PBX3	1.01e-05	2	111	2	32144534
Pubmed	KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	30689576
Pubmed	Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.	KIR2DS2 KIR2DL3	1.01e-05	2	111	2	18158964
Pubmed	The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	22024796
Pubmed	Killer cell immunoglobulin-like receptor polymorphisms in HLA-identical kidney transplant recipients: lack of 2DL2 and 2DS2 may be associated with poor graft function.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	17445184
Pubmed	Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	26202659
Pubmed	Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers.	KIR2DL2 KIR2DL3	1.01e-05	2	111	2	22715396
Pubmed	Association of killer cell immunoglobulin-like receptors with scleroderma.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	15146426
Pubmed	Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	25636579
Pubmed	[Correlation analysis between killer cell immunoglobulin-like receptor gene polymorphism and primary biliary cirrhosis].	KIR2DS2 KIR2DL2	1.01e-05	2	111	2	25575065
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	ACTN4 NF1 UBR5 OSBPL6 SCP2 MACF1 EXOG ATP2B1 SCAI	1.03e-05	430	111	9	32581705
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	SRP54 ACTN4 SLC3A2 TFRC SVIL ASNS MACF1	1.10e-05	235	111	7	28378594
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DL2 KIR2DL3	1.12e-05	14	111	3	19875891
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DL2 KIR2DL3	1.12e-05	14	111	3	19489269
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DL2 KIR2DL3	1.12e-05	14	111	3	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DL2 KIR2DL3	1.12e-05	14	111	3	15896204
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	BCL9L CKAP5 NSD1 ACTN4 CREBBP TARDBP SVIL MACF1	1.19e-05	332	111	8	37433992
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CKAP5 NBEA ACTN4 SLC1A2 RBM39 SLC3A2 ERLIN2 NF1 SVIL OSBPL6 MACF1 ATP2B1 ATP2B2 CAPRIN1 SCAI DNAH11	1.27e-05	1431	111	16	37142655
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	20082646
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	19850842
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	19493232
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DL2 KIR2DL3	1.40e-05	15	111	3	19326408
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	SLC4A7 ZFYVE16 CKAP5 SRP54 NBEA SLC3A2 TFRC ERLIN2 IGF2R	1.45e-05	449	111	9	31732153
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	LAMP1 SLC3A2 ITFG1 TFRC ERLIN2 IGF2R	1.51e-05	164	111	6	32409323
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	BCL9L SLC4A7 CKAP5 TNRC6B NBEA ACTN4 LRP1B SLC1A2 RBM39 SLC3A2 ERLIN2 NF1 MACF1 CAPRIN1	1.65e-05	1139	111	14	36417873
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	18668235
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	16403292
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	20652381
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DL2 KIR2DL3	1.72e-05	16	111	3	18643961
Interaction	NUP43 interactions	BCL9L HIVEP1 ZNF280D RBBP8 PHF12 NSD1 TNRC6B PHF8 RBM39 EMSY DHX8 TDRD7 UBR5 CEBPZ MCM3AP ZFHX3	2.19e-07	625	108	16	int:NUP43
Interaction	EGR2 interactions	BCL9L HIVEP1 PHF12 SSBP2 CREBBP EMSY TLE1 ZFHX3	3.90e-06	171	108	8	int:EGR2
Interaction	LAMP2 interactions	SLC4A7 ZFYVE16 LAMP1 NBEA GPRC5C CYP2S1 CREBBP RBM39 SLC3A2 TFRC SCYL2 IGF2R EFR3B ATP2B1	4.67e-06	609	108	14	int:LAMP2
Interaction	STX6 interactions	SLC4A7 ZFYVE16 LAMP1 NBEA SLC3A2 TFRC SCYL2 IGF2R OSBPL6 EFR3B MACF1 ATP2B1	5.10e-06	448	108	12	int:STX6
Interaction	H3-4 interactions	SOX6 PHF12 SGTA TAF1A NSD1 PHF8 CREBBP RBM39 EMSY TBC1D4 SVIL EXOG	5.10e-06	448	108	12	int:H3-4
Interaction	TLE3 interactions	SOX6 BCL9L HIVEP1 RBBP8 CREBBP EMSY TBC1D4 UBR5 TLE1 MCM3AP ZFHX3	5.64e-06	376	108	11	int:TLE3
Interaction	RAB4A interactions	SLC4A7 ZFYVE16 LAMP1 NBEA GPRC5C SLC3A2 TFRC SCYL2 VPS13D IGF2R EFR3B ATP2B1	6.24e-06	457	108	12	int:RAB4A
Interaction	DIRAS3 interactions	SLC4A7 NBEA SLC3A2 TFRC SCYL2 IGF2R EFR3B MACF1 ATP2B1	1.18e-05	262	108	9	int:DIRAS3
Interaction	AR interactions	BCL9L MED18 HIVEP1 PHF12 NSD1 POU3F3 ACTN4 SSBP2 CREBBP EMSY TARDBP UBR5 TLE1 SVIL ASNS ZFHX3 VAV2	2.05e-05	992	108	17	int:AR
Interaction	TYRO3 interactions	ARHGEF5 LAMP1 SLC3A2 TFRC ERLIN2 IGF2R ATP2B1	2.48e-05	160	108	7	int:TYRO3
Interaction	ATG9A interactions	ZFYVE16 NBEA SLC3A2 ITFG1 TFRC SCYL2 IGF2R NF1 GNA13 ATP2B2 CAPRIN1	2.71e-05	445	108	11	int:ATG9A
Interaction	ZFPL1 interactions	SLC4A7 LAMP1 NBEA SLC3A2 TFRC SCYL2 VPS13D IGF2R OSBPL6 EFR3B ATP2B1	2.88e-05	448	108	11	int:ZFPL1
Interaction	SNRNP40 interactions	ESPN BCL9L HIVEP1 ZNF280D RBBP8 PHF12 PHF8 RBM39 EMSY DHX8 UBR5 CEBPZ ZFHX3	3.65e-05	637	108	13	int:SNRNP40
Interaction	RNF186 interactions	HIVEP1 TFRC PBX3	4.12e-05	13	108	3	int:RNF186
Interaction	BET1 interactions	SLC4A7 ZFYVE16 NBEA TFG SLC3A2 TFRC SCYL2 ERLIN2 IGF2R ATP2B1	4.23e-05	385	108	10	int:BET1
Interaction	ETS1 interactions	HIVEP1 PHF12 ETS2 CREBBP EMSY ATP2B1	4.80e-05	121	108	6	int:ETS1
Interaction	HDAC1 interactions	SOX6 MED18 HIVEP1 ZFYVE16 RBBP8 PHF12 CKAP5 TNRC6B CREBBP RBM39 EMSY ITFG1 TBC1D4 UBR5 TLE1 ZFHX3 CAPRIN1	8.15e-05	1108	108	17	int:HDAC1
Interaction	PHF21A interactions	HIVEP1 ZFYVE16 RBBP8 PHF12 CKAP5 TNRC6B TBC1D4 UBR5 ZFHX3	9.62e-05	343	108	9	int:PHF21A
Interaction	GSC interactions	BCL9L HIVEP1 CREBBP TLE1 ZFHX3	1.05e-04	87	108	5	int:GSC
Interaction	LYN interactions	SLC4A7 ARHGEF5 PECAM1 LAMP1 PHF8 CREBBP SLC3A2 TFRC NF1 SVIL EFR3B MACF1 ATP2B1	1.26e-04	720	108	13	int:LYN
Interaction	RHOQ interactions	SLC4A7 ZFYVE16 GPRC5C SLC3A2 TFRC SCYL2 IGF2R NF1 EFR3B ATP2B1	1.33e-04	442	108	10	int:RHOQ
Interaction	CAV1 interactions	SLC4A7 ZFYVE16 LAMP1 SLC3A2 TFRC TARDBP IGF2R NF1 EFR3B SCP2 MACF1 ATP2B1 VAV2	1.33e-04	724	108	13	int:CAV1
Interaction	OPALIN interactions	SLC4A7 GPRC5C CYP2S1 NF1 XPO6 ATP2B1 ATP2B2	1.34e-04	209	108	7	int:OPALIN
Interaction	FLOT2 interactions	SOX6 LAMP1 TFG ITFG1 TFRC TARDBP ERLIN2 SVIL	1.50e-04	285	108	8	int:FLOT2
Interaction	RHOB interactions	SLC4A7 ZFYVE16 NBEA SLC3A2 TFRC SCYL2 IGF2R NF1 GNA13 ASNS OSBPL6 EFR3B MACF1 ATP2B1	1.58e-04	840	108	14	int:RHOB
Interaction	RIPPLY2 interactions	TFG TLE1 EXOG	1.60e-04	20	108	3	int:RIPPLY2
Interaction	SIRT7 interactions	CKAP5 NSD1 ACTN4 RBM39 DHX8 IGF2R NF1 UBR5 CEBPZ MCM3AP ASNS MACF1 CAPRIN1	1.74e-04	744	108	13	int:SIRT7
Interaction	NTRK3 interactions	SLC4A7 NSD1 LAMP1 NBEA TFG SLC3A2 TFRC IGF2R ASNS	1.84e-04	374	108	9	int:NTRK3
Interaction	MYH15 interactions	ACTN4 TFRC ATP2B2	1.86e-04	21	108	3	int:MYH15
Interaction	DNAJC5 interactions	SLC4A7 SGTA SRP54 SLC3A2 TFRC IGF2R EFR3B MACF1 ATP2B1	2.00e-04	378	108	9	int:DNAJC5
Interaction	ERG interactions	SOX6 HIVEP1 ETS2 CREBBP EMSY UBR5 TLE1	2.00e-04	223	108	7	int:ERG
Interaction	CCDC8 interactions	GAS2L3 CKAP5 LAMP1 ACTN4 SLC3A2 IGF2R NF1 UBR5 GNA13 SVIL MACF1 ATP2B1	2.06e-04	656	108	12	int:CCDC8
Interaction	STX7 interactions	SLC4A7 ZFYVE16 LAMP1 NBEA GPRC5C SLC3A2 TFRC SCYL2 IGF2R EFR3B SCP2 ATP2B1	2.15e-04	659	108	12	int:STX7
Interaction	NFIX interactions	SOX6 HIVEP1 PHF12 ACTN4 EMSY TLE1 ZFHX3	2.23e-04	227	108	7	int:NFIX
Interaction	MEX3A interactions	BCL9L CKAP5 NSD1 R3HDM2 ACTN4 CREBBP TARDBP SVIL MACF1	2.24e-04	384	108	9	int:MEX3A
Interaction	RAB2A interactions	SLC4A7 LAMP1 NBEA GPRC5C RBM39 SLC3A2 TFRC ERLIN2 IGF2R EFR3B ATP2B1	2.33e-04	567	108	11	int:RAB2A
Interaction	CDC73 interactions	BCL9L ACTN4 SLC3A2 DHX8 ITFG1 TFRC UBR5 GNA13 MCM3AP	2.33e-04	386	108	9	int:CDC73
Interaction	CDH1 interactions	SLC4A7 ZFYVE16 CKAP5 ACTN4 CREBBP SLC3A2 SCYL2 IGF2R GNA13 SVIL MACF1 ATP2B1 CAPRIN1	2.37e-04	768	108	13	int:CDH1
Interaction	FLOT1 interactions	SOX6 SLC4A7 SLC3A2 TFRC ERLIN2 NF1 SVIL EFR3B MACF1 ATP2B1	2.37e-04	475	108	10	int:FLOT1
Interaction	ZFYVE9 interactions	ZFYVE16 ETS2 LAMP1 TFRC SCYL2	2.66e-04	106	108	5	int:ZFYVE9
Interaction	RAB3B interactions	SLC4A7 LAMP1 SLC3A2 TFRC SCYL2 VPS13D IGF2R ATP2B1	2.66e-04	310	108	8	int:RAB3B
Interaction	CCDC144A interactions	NF1 CCDC144A	2.82e-04	5	108	2	int:CCDC144A
Interaction	LAMP3 interactions	SLC4A7 ZFYVE16 NBEA GPRC5C SLC3A2 TFRC SCYL2 IGF2R EFR3B ATP2B1	2.85e-04	486	108	10	int:LAMP3
Interaction	GJA1 interactions	SLC4A7 ZFYVE16 LAMP1 NBEA SLC3A2 TFRC SCYL2 IGF2R EFR3B MACF1 ATP2B1	2.95e-04	583	108	11	int:GJA1
Interaction	TFRC interactions	ZFYVE16 SGTA LAMP1 NBEA ACTN4 RBM39 ITFG1 TFRC SCYL2 ERLIN2	2.99e-04	489	108	10	int:TFRC
Interaction	CAMSAP2 interactions	GAS2L3 CREBBP TDRD7 NF1 OSBPL6 MACF1	3.01e-04	169	108	6	int:CAMSAP2
Interaction	RCOR1 interactions	SOX6 HIVEP1 ZFYVE16 RBBP8 PHF12 CKAP5 TNRC6B ITFG1 UBR5 ZFHX3	3.24e-04	494	108	10	int:RCOR1
Interaction	TMEM17 interactions	SLC4A7 NBEA TFG SLC3A2 TFRC SCYL2 IGF2R EFR3B ATP2B1	3.26e-04	404	108	9	int:TMEM17
Interaction	SHANK3 interactions	BCL9L PHF12 CKAP5 ACTN4 TDRD7 IGF2R NF1 MACF1 ZFHX3 ATP2B2	3.34e-04	496	108	10	int:SHANK3
Interaction	ANPEP interactions	NBEA ACTN4 SLC3A2 TFRC ERLIN2 IGF2R	3.51e-04	174	108	6	int:ANPEP
Interaction	TBR1 interactions	BCL9L HIVEP1 RBM39 TLE1 ZFHX3	3.57e-04	113	108	5	int:TBR1
Interaction	YWHAE interactions	HIVEP1 SLC4A7 ARHGEF5 CKAP5 R3HDM2 ACTN4 RBM39 ITFG1 TARDBP PANK2 TBC1D4 NF1 SVIL ASNS OSBPL6 MACF1 CAPRIN1	3.62e-04	1256	108	17	int:YWHAE
Interaction	LDB1 interactions	SOX6 BCL9L SSBP2 TARDBP ZFHX3	3.87e-04	115	108	5	int:LDB1
Interaction	DHX40 interactions	SOX6 NSD1 PHF8 RBM39 DHX8 UBR5 CEBPZ	3.90e-04	249	108	7	int:DHX40
Interaction	SEC62 interactions	SLC4A7 SRP54 GPR183 SLC3A2 TFRC EVI5 IGF2R XPO6 EXOG ATP2B1	3.91e-04	506	108	10	int:SEC62
Interaction	RHOU interactions	SLC4A7 ZFYVE16 GPRC5C SLC3A2 TFRC IGF2R GNA13 EFR3B MACF1 ATP2B1	4.16e-04	510	108	10	int:RHOU
Interaction	PYGO1 interactions	BCL9L SSBP2 UBR5	4.45e-04	28	108	3	int:PYGO1
Interaction	LILRB4 interactions	ITFG1 ATP2B1 ATP2B2	4.45e-04	28	108	3	int:LILRB4
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL2 KIR2DL3	4.93e-05	18	73	3	620
GeneFamily	ATPases Ca2+ transporting	ATP2B1 ATP2B2	5.68e-04	9	73	2	1209
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	PHF12 EMSY	1.03e-03	12	73	2	1243
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	PECAM1 KIR2DS2 LAMP1 TFRC IGF2R KIR2DL2 KIR2DL3	1.05e-03	394	73	7	471
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HIVEP1 SLC4A7 ZFYVE16 CKAP5 R3HDM2 SSBP2 PHF8 CREBBP RBM39 TDRD7 EVI5 IGF2R UBR5 XPO6 TLE1 SERPINB2 MACF1 ZFHX3 PBX3 ATP2B1	4.98e-10	856	111	20	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	HIVEP1 SLC4A7 CKAP5 R3HDM2 CREBBP RBM39 TDRD7 EVI5 UBR5 TLE1 PBX3 ATP2B1	6.96e-07	466	111	12	M13522
Coexpression	RODRIGUES_NTN1_AND_DCC_TARGETS	ETS2 NFKBIZ TBC1D4 NF1	1.44e-05	35	111	4	M3346
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ETS2 NBEA LRP1B SLC1A2 EBF2 ASNS OSBPL6 CNTNAP4 ZFHX3 PBX3 ATP2B1 UNC79 ATP2B2 VAV2 CCDC144A SCAI	1.71e-05	1106	111	16	M39071
Coexpression	GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN	SLC4A7 ETS2 PRSS23 IGF2R SVIL ZFHX3 PBX3	2.28e-05	199	111	7	M8197
Coexpression	GSE3982_EOSINOPHIL_VS_BASOPHIL_DN	ZFYVE16 SRP54 R3HDM2 TARDBP NF1 CAPRIN1 VAV2	2.28e-05	199	111	7	M5414
Coexpression	GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN	PHF12 ETS2 LAMP1 NFKBIZ SSBP2 RBM39 SLC3A2	2.36e-05	200	111	7	M5837
Coexpression	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN	SLC4A7 NSD1 SSBP2 ABHD4 NF1 USP27X VAV2	2.36e-05	200	111	7	M5715
Coexpression	GSE7460_TCONV_VS_TREG_LN_DN	SLC4A7 NFKBIZ TDRD7 TBC1D4 ASNS USP27X VAV2	2.36e-05	200	111	7	M5674
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	SOX6 ARHGEF5 ETS2 NFKBIZ NBEA SSBP2 PRSS23 SLC3A2 IGF2R TLE1 MACF1 PBX3	5.62e-05	721	111	12	M1999
Coexpression	HEDENFALK_BREAST_CANCER_BRACX_DN	EVI5 UBR5 SVIL	8.00e-05	20	111	3	M8941
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	MED18 GAS2L3 SRP54 SSBP2 PRSS23 CREBBP ATP2B1 SCAI	3.35e-05	249	105	8	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	SOX6 CACNA1F ZNF280D PHF12 POU3F3 XPNPEP2 TFG SLC1A2 DHX8 SCP2 MACF1 USP27X	3.82e-05	595	105	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	MED18 ZNF280D GAS2L3 NBEA SSBP2 PRSS23 CREBBP RBM39 IGF2R NOTUM GNA13 ZFHX3 ATP2B1 SCAI	4.02e-05	801	105	14	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_200	MED18 SSBP2 ATP2B1 SCAI	4.50e-05	40	105	4	gudmap_developingGonad_P2_epididymis_200_k3
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_100	SSBP2 RBM39 SCAI	5.12e-05	15	105	3	gudmap_developingGonad_e12.5_epididymis_k2_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	SLC4A7 ZNF280D PHF12 CKAP5 NFKBIZ POU3F3 XPNPEP2 TFG DHX8 SCP2 MACF1 USP27X	6.51e-05	629	105	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4	SLC4A7 ZNF280D PHF12 XPNPEP2 SCP2 MACF1 USP27X	6.79e-05	203	105	7	Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	MED18 GAS2L3 SSBP2 RBM39 ATP2B1 SCAI	1.02e-04	150	105	6	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	CACNA1F SLC4A7 ZNF280D CKAP5 NFKBIZ POU3F3 SLC1A2 EBF2 PANK2 MCM3AP BPIFB4 MACF1 ZFHX3 USP27X ATP2B2	1.04e-04	989	105	15	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000	MED18 GAS2L3 SSBP2 CREBBP RBM39 SCAI	1.06e-04	151	105	6	gudmap_developingGonad_P2_ovary_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	HIVEP1 SLC4A7 ZNF280D XPNPEP2 TFG DHX8 XPO6 SCP2 MACF1 ZFHX3 USP27X	1.10e-04	564	105	11	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200	MED18 SSBP2 RBM39 ATP2B1 CNN1 SCAI	1.31e-04	157	105	6	gudmap_developingGonad_P2_epididymis_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	GAS2L3 NSD1 SRP54 RBM39 TFRC ZDHHC15 GNA13 ATP2B1 CAPRIN1	1.58e-04	397	105	9	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200	MED18 SSBP2 RBM39 SCAI	2.37e-04	61	105	4	gudmap_developingGonad_e12.5_epididymis_k2_200
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_100	SSBP2 RBM39 SCAI	2.50e-04	25	105	3	gudmap_developingGonad_e11.5_ovary + mesonephros_k3_100
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200	SSBP2 RBM39 SCAI	2.81e-04	26	105	3	gudmap_developingGonad_e18.5_ovary_200_k3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_100	SSBP2 RBM39 SCAI	2.81e-04	26	105	3	gudmap_developingGonad_e12.5_ovary_k1_100
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200	MED18 SSBP2 ATP2B1 SCAI	2.86e-04	64	105	4	gudmap_developingGonad_e18.5_epididymis_200_k5
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500	MED18 SSBP2 RBM39 SCAI	3.03e-04	65	105	4	gudmap_developingGonad_P2_ovary_500_k2
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	MED18 SLC4A7 GAS2L3 SSBP2 CREBBP ATP2B1 SCAI	3.05e-04	259	105	7	gudmap_developingGonad_e12.5_epididymis_k3_1000
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ETS2 NFKBIZ GPR183 TFRC GNA13 SERPINB2 ATP2B1	6.45e-07	199	110	7	880ba91ccecc6633f6daba7822d9200548a8632f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HIVEP1 GPR183 EBF2 ZDHHC15 TBC1D4 ASNS	3.72e-06	167	110	6	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	COVID-19-Myeloid-MoAM5,_CCL3L1\|Myeloid / Condition, Lineage and Cell class	HIVEP1 ZFYVE16 ETS2 NFKBIZ GPR183 UNC79	3.85e-06	168	110	6	ea465152ea31391b63c02425beafa9a4f51f6703
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS23 NOTUM TLE1 SVIL ZFHX3 PBX3	6.70e-06	185	110	6	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS23 EBF2 TLE1 SVIL ZFHX3 PBX3	6.90e-06	186	110	6	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SSBP2 PRSS23 NOTUM TLE1 SVIL ZFHX3	7.12e-06	187	110	6	5258674d0346e5c51a4b965efcdc1790c970845d
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 PECAM1 ARAP3 TLE1 ASNS CNTNAP4	7.57e-06	189	110	6	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	(12)_SLC16A7+\|World / shred by cell type by condition	TAF1A ZBBX ZDHHC15 ZNF713 DLEC1 DNAH11	8.03e-06	191	110	6	e427eeddd2e87c14376a37db0b43f120c90436bc
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SOX6 SSBP2 LRP1B EBF2 NOTUM PBX3	8.28e-06	192	110	6	d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|(1)_Control_(PBS) / Stress and Cell class	PECAM1 ETS2 NBEA TBC1D4 ARAP3 SVIL	8.28e-06	192	110	6	e16e49b302019474232ef4cc0ff217d33afe34cf
ToppCell	Control-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	ZFYVE16 ETS2 GPR183 TFRC SERPINB2 ATP2B1	8.78e-06	194	110	6	c35bf04d5e7450cb6679a036fcabb1b28f409f29
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ACTN4 PRSS23 IGF2R TLE1 MACF1 KIR2DL2	9.86e-06	198	110	6	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NBEA OSBPL6 ATP2B1 UNC79 ATP2B2 SCAI	9.86e-06	198	110	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ACTN4 PRSS23 IGF2R TLE1 MACF1 KIR2DL2	9.86e-06	198	110	6	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	Control-NK\|Control / Disease condition and Cell class	ACTN4 PRSS23 IGF2R TLE1 MACF1 KIR2DL3	1.01e-05	199	110	6	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SOX6 PECAM1 ARAP3 TLE1 ASNS CNTNAP4	1.04e-05	200	110	6	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRSS23 PLEKHD1 UBR5 TLE1 ASNS	4.98e-05	161	110	5	9cfbbcd38ec2e75376bbc26001964b6991ad0e21
ToppCell	Ciliated_cells-B-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	ZBBX ZNF713 OSBPL6 CFAP206 DNAH11	5.76e-05	166	110	5	4b1056aad8a99827835242b8ab0c7f2bb84471f1
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SOX6 POU3F3 GPRC5C KLHL31 NOTUM	5.93e-05	167	110	5	102b3d160a44c8623fab1fd10e9054178c42a78b
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GAS2L3 NBEA LRP1B DHX8 EBF2	7.01e-05	173	110	5	b43817a6b1ed8d6b5366702343be4311c0d52d83
ToppCell	CV-Mild-6\|Mild / Virus stimulation, Condition and Cluster	TNRC6B CREBBP SCYL2 ZNF713 IGF2R	7.40e-05	175	110	5	c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKAP5 NSD1 SRP54 TBC1D4 MACF1	7.60e-05	176	110	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACTN4 CCDC144CP ZBBX TLE1 AIFM3	8.02e-05	178	110	5	674ee5095b98929c29e4f6bd56029a336cc4a38c
ToppCell	facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRC5C PRSS23 PLEKHD1 ZFHX3 CNN1	8.67e-05	181	110	5	429df38438d5a7ff490c9ede34b69e2970c7ded2
ToppCell	facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRC5C PRSS23 PLEKHD1 ZFHX3 CNN1	8.67e-05	181	110	5	395cf5aa2d89b05328ab516b8c89401020b6d830
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HIVEP1 R3HDM2 TBC1D4 XPO6 LRRC37B	9.13e-05	183	110	5	807d64deaf4e50dccf6f831f88578a6d903c1421
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZFYVE16 RBBP8 PHF8 TBC1D4 SCAI	9.13e-05	183	110	5	fef51dcf180e6d4e136362c7e140ec5ef372e6d0
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F LRP1B CNTNAP4 UNC79 DNAH11	9.37e-05	184	110	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD1 SRP54 NFKBIZ CEBPZ MACF1	9.37e-05	184	110	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F LRP1B CNTNAP4 UNC79 DNAH11	9.37e-05	184	110	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F LRP1B CNTNAP4 UNC79 DNAH11	9.37e-05	184	110	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	APOBEC4 ZBBX CFAP206 DLEC1 DNAH11	9.61e-05	185	110	5	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ZBBX OSBPL6 CFAP206 DLEC1 DNAH11	9.61e-05	185	110	5	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	APOBEC4 ZBBX CFAP206 DLEC1 DNAH11	9.86e-05	186	110	5	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 PECAM1 LRP1B ASNS CNTNAP4	9.86e-05	186	110	5	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	APOBEC4 ZBBX CFAP206 DLEC1 DNAH11	9.86e-05	186	110	5	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	APOBEC4 ZBBX CFAP206 DLEC1 DNAH11	9.86e-05	186	110	5	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX6 RBBP8 ETS2 SSBP2 SERPINB2	1.01e-04	187	110	5	9c1013720c248ef201d010806b6e7ad24205e8ee
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	TNRC6B RBM39 IGF2R NF1 MACF1	1.04e-04	188	110	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	10x3'2.3-week_14-16-Myeloid_DC-DC-DC2\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ETS2 GPR183 CYP2S1 LRP1B ATP2B1	1.04e-04	188	110	5	15d8dc514d5da46f6af284e7c1c92c606712dae6
ToppCell	(7)_Epithelial-F_(Ciliated)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	APOBEC4 ZBBX CFAP206 DLEC1 DNAH11	1.04e-04	188	110	5	9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GPR183 NOTUM TLE1 ZFHX3 CNN1	1.06e-04	189	110	5	b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP2S1 ZBBX OSBPL6 CFAP206 DNAH11	1.06e-04	189	110	5	02c6128a9ab5818e0881dcadafdad5f08b9a67cf
ToppCell	droplet-Heart-HEART-1m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS2L3 PRSS23 BPIFB4 SERPIND1 DNAH11	1.06e-04	189	110	5	a618a1ddf5097a010c6c2c7341f3a0bd46a29c02
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP2S1 ZBBX OSBPL6 CFAP206 DNAH11	1.06e-04	189	110	5	164ea92ff6a1aa2ead1c9b8f64f99a9d65437232
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC4A7 SSBP2 LRP1B SLC1A2 TBC1D4	1.06e-04	189	110	5	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS2L3 PRSS23 BPIFB4 SERPIND1 DNAH11	1.06e-04	189	110	5	4e61f9cd1c06bddb47ebf98affc0f97770e26e8c
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP2S1 ZBBX OSBPL6 CFAP206 DNAH11	1.06e-04	189	110	5	a85099bd598a27ee64ee0664d051d89fa8d62fc9
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 PECAM1 ARAP3 ASNS CNTNAP4	1.09e-04	190	110	5	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PECAM1 XPNPEP2 ASNS ZFHX3 DNAH11	1.12e-04	191	110	5	df8cdbc26443e55a203cbafa21b0952a2a55b9bf
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 PECAM1 ARAP3 ASNS CNTNAP4	1.12e-04	191	110	5	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 TNRC6B RBM39 NOTUM UBR5	1.14e-04	192	110	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	367C-Myeloid-Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ETS2 NFKBIZ GPR183 SERPINB2 ATP2B1	1.14e-04	192	110	5	26326d7c3d907d754e85e128b7d8a52e90863f3f
ToppCell	CTRL-Myeloid-Alveolar_Macrophage\|Myeloid / Disease state, Lineage and Cell class	PECAM1 TFRC TBC1D4 SVIL SCP2	1.17e-04	193	110	5	80871d963c23a6befe58e5e60b7f7d1a1b227ce2
ToppCell	367C-Myeloid-Monocyte-CD14+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ETS2 NFKBIZ GPR183 SERPINB2 ATP2B1	1.17e-04	193	110	5	c7ecd98729419b34c14f9b387b15472c47951d2f
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	PRSS23 RBM39 IGF2R TLE1 KIR2DL3	1.17e-04	193	110	5	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	normal_Lymph_Node-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	HIVEP1 SLC1A2 HMSD TBC1D4 ATP2B1	1.17e-04	193	110	5	024d30eb143d8278c0851c3a6c9426226fa3b480
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 TNRC6B RBM39 NOTUM UBR5	1.17e-04	193	110	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACTN4 PRSS23 IGF2R MACF1 KIR2DL3	1.20e-04	194	110	5	24837a27b0041fe8c348225fa8b09b127d743603
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM5-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ETS2 LAMP1 NFKBIZ SLC3A2 SERPINB2	1.20e-04	194	110	5	c53478057674d70b79df8a3f476d15dea1925753
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	APOBEC4 ZBBX CFAP206 DLEC1 DNAH11	1.20e-04	194	110	5	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM5\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ETS2 LAMP1 NFKBIZ SLC3A2 SERPINB2	1.20e-04	194	110	5	2ab3f75b795a0ee4fe0f8eeba33093fcc77935f5
ToppCell	368C-Myeloid-Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZFYVE16 NFKBIZ GPR183 SERPINB2 ATP2B1	1.20e-04	194	110	5	f9b9cbd1a418a7cbd151c2425fda6b864db9aa82
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	ZNF717 ARHGEF5 EVI5 UBR5 EFR3B	1.20e-04	194	110	5	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM5-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ETS2 LAMP1 NFKBIZ SLC3A2 SERPINB2	1.20e-04	194	110	5	8805c90e4284a81a6c8078f2d2417ae77b4e5c63
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ETS2 LAMP1 NFKBIZ SLC3A2 SERPINB2	1.20e-04	194	110	5	86d52467b05a0018517377c9c441245501f71d91
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	PRSS23 RBM39 IGF2R TLE1 KIR2DL3	1.20e-04	194	110	5	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	ZNF717 ARHGEF5 EVI5 UBR5 EFR3B	1.20e-04	194	110	5	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	metastatic_Brain-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	PRSS23 RBM39 IGF2R TLE1 KIR2DL3	1.23e-04	195	110	5	184471f71b8bbffec12ebb8dd6a0af589e021c02
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A7 NSD1 NBEA MACF1 ATP2B1	1.23e-04	195	110	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Severe_COVID-19-Myeloid-MoAM5\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ETS2 LAMP1 NFKBIZ SLC3A2 SERPINB2	1.23e-04	195	110	5	6d768454ed630e586431535400507074eea76dd1
ToppCell	368C-Myeloid-Monocyte-CD14+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZFYVE16 NFKBIZ GPR183 SERPINB2 ATP2B1	1.23e-04	195	110	5	8da933942e9033e18e25ab47831c269747b1c0b2
ToppCell	343B-Myeloid-Monocyte-CD14+_Monocyte\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZFYVE16 NFKBIZ GPR183 SERPINB2 ATP2B1	1.23e-04	195	110	5	b5ee368c97113432fc8fe742654cd538558f327c
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	PECAM1 ETS2 NBEA ARAP3 SVIL	1.23e-04	195	110	5	6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZBBX OSBPL6 CFAP206 DLEC1 DNAH11	1.26e-04	196	110	5	a37ba02446eef5d1fab703204583f6550a8ec3e1
ToppCell	368C-Myeloid-Monocyte-CD14+_Monocyte\|368C / Donor, Lineage, Cell class and subclass (all cells)	ETS2 NFKBIZ GPR183 SERPINB2 ATP2B1	1.26e-04	196	110	5	8095b3c1a87ce5c1c7dcbd951806fa564c795068
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NBEA ATP2B1 UNC79 ATP2B2 SCAI	1.26e-04	196	110	5	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	368C-Myeloid-Monocyte\|368C / Donor, Lineage, Cell class and subclass (all cells)	ETS2 NFKBIZ GPR183 SERPINB2 ATP2B1	1.26e-04	196	110	5	3b46a501590aa03e3b7e25943dd43b72ecaf8182
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZBBX OSBPL6 CFAP206 DLEC1 DNAH11	1.26e-04	196	110	5	a156840330630e518bc85633dded6f2c3ead3b30
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZBBX OSBPL6 CFAP206 DLEC1 DNAH11	1.26e-04	196	110	5	009e83c7251cf300be78b263634d233a8d972a68
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIVEP1 ZFYVE16 GPR183 GNA13 ATP2B1	1.26e-04	196	110	5	c2bbb48c4aa979b03cb6f4ce9f351f492977c992
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACTN4 PRSS23 IGF2R TLE1 KIR2DL3	1.26e-04	196	110	5	78b28b263deaa43590b38597186222c6447ad25f
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZBBX OSBPL6 CFAP206 DLEC1 DNAH11	1.26e-04	196	110	5	89ea4d2086e1c769c5a87f1471a6cd4acabcfe33
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIVEP1 ZFYVE16 GPR183 GNA13 ATP2B1	1.26e-04	196	110	5	64c2abc0087bf2ae547932377f3662e3be1cc63e
ToppCell	(3)_MNP-(3)_Monocyte\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	ETS2 NFKBIZ GPR183 SERPINB2 ATP2B1	1.26e-04	196	110	5	83af2eb1c28dfe7678d972be1d6d358c4a94731d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACTN4 PRSS23 IGF2R TLE1 KIR2DL3	1.26e-04	196	110	5	3e78e307c9c991c1aadc85c61d401431cf75eaec
ToppCell	10x5'-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	ACTN4 PRSS23 IGF2R TLE1 KIR2DL3	1.26e-04	196	110	5	1868ad537b7f04cdad0a0c8282aadbc4f257a722
ToppCell	lymphoid-T_cell-unlabelled(multiplets)\|T_cell / Lineage, cell class and subclass	GPR183 RBM39 SLC3A2 CEBPZ GNA13	1.29e-04	197	110	5	f215435aee15f0ed254104bfd55670144b6d2ac3
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CYP2S1 SLC1A2 ZBBX CFAP206 DNAH11	1.29e-04	197	110	5	861e8df9bd74dc5e17bafdc1fb3fef546753c73a
ToppCell	T/NK_cells-CD56dim_NK_cell\|T/NK_cells / Lineage and Cell class	PRSS23 IGF2R TLE1 SCP2 KIR2DL3	1.29e-04	197	110	5	722d00a218755cc8cb7b5ab2a7fca40269247c3a
ToppCell	lymphoid-T_cell-unlabelled(multiplets)\|lymphoid / Lineage, cell class and subclass	GPR183 RBM39 SLC3A2 CEBPZ GNA13	1.29e-04	197	110	5	a224c0a010489ad043bd2ad1385eef33c3b6b792
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LAMP1 ACTN4 PRSS23 TLE1 KIR2DL3	1.29e-04	197	110	5	d2f7ba404a0340e12ccbd3f9d76c8d782584e775
ToppCell	normal_Lung-Myeloid_cells-Monocytes\|normal_Lung / Location, Cell class and cell subclass	ETS2 NFKBIZ GPR183 SERPINB2 ATP2B1	1.29e-04	197	110	5	f32f1a0455c2cfdd5f187b10f6a3fd4877874c09
ToppCell	COVID-19_Severe-NK\|COVID-19_Severe / Disease condition and Cell class	ACTN4 PRSS23 IGF2R TLE1 KIR2DL3	1.32e-04	198	110	5	742c4d6016cfa48444a5919a885ab8d02cad7e18
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NBEA OSBPL6 ATP2B1 UNC79 ATP2B2	1.32e-04	198	110	5	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	356C-Myeloid-Monocyte-CD14+_Monocyte\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZFYVE16 ETS2 GPR183 SERPINB2 ATP2B1	1.32e-04	198	110	5	8f53df66712c0b4a176098c0dbb3c2c13d3f56df
ToppCell	(3)_Monocyte\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ZFYVE16 ETS2 GPR183 SERPINB2 ATP2B1	1.32e-04	198	110	5	dff753c3d6919ea9f504bdc9859ed542a5490a9d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NBEA OSBPL6 ATP2B1 UNC79 ATP2B2	1.32e-04	198	110	5	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	390C-Lymphocytic-NK_cells\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ACTN4 PRSS23 IGF2R TLE1 KIR2DL3	1.32e-04	198	110	5	623e5ada1a54cd42c32a1519b84dbe782384ee0c
ToppCell	myeloid-Dendritic_cell-Conventional_dendritic_cell\|World / Lineage, cell class and subclass	ETS2 ACTN4 GPR183 CYP2S1 GNA13	1.32e-04	198	110	5	2ec42643200aa9feb33e2b87570f276fbad21cad
Drug	Magnetite Nanoparticles	HIVEP1 SLC4A7 ZNF280D ZFYVE16 RBBP8 ETS2 NSD1 TNRC6B NFKBIZ GPR183 CYP2S1 CREBBP RBM39 TFRC EVI5 TARDBP TBC1D4 ARAP3 GNA13 ATP2B1 SERPIND1	1.07e-06	1310	110	21	ctd:D058185
Drug	Succimer	HIVEP1 SLC4A7 ZNF280D ZFYVE16 RBBP8 ETS2 NSD1 TNRC6B NFKBIZ CYP2S1 CREBBP RBM39 TFRC EVI5 TARDBP TBC1D4 ARAP3 GNA13 ATP2B1 SERPIND1	2.45e-06	1264	110	20	ctd:D004113
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ETS2 TNRC6B EMSY ABHD4 EVI5 NF1 ZFHX3 EXOG	4.87e-06	195	110	8	6821_DN
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; HL60; HT_HG-U133A	ETS2 TNRC6B LAMP1 ABHD4 NF1 ARAP3 GNA13 CAPRIN1	5.45e-06	198	110	8	1328_DN
Drug	Gliclazide [21187-98-4]; Down 200; 12.4uM; HL60; HG-U133A	SLC4A7 ZNF280D SCYL2 EVI5 TBC1D4 NF1 UBR5 DMAC2L	5.87e-06	200	110	8	1720_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	HIVEP1 SSBP2 CREBBP NF1 UBR5 SVIL ATP2B1	2.22e-05	174	110	7	7530_DN
Drug	Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	MED18 LAMP1 SSBP2 SCYL2 NF1 GNA13 CAPRIN1	3.76e-05	189	110	7	6793_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	ZNF821 MED18 SCYL2 NF1 TLE1 GNA13 MCM3AP	4.44e-05	194	110	7	4736_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	LAMP1 SCYL2 VPS13D TLE1 MCM3AP CNN1 VAV2	4.59e-05	195	110	7	3862_UP
Drug	Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A	ZNF280D VPS13D ERLIN2 NF1 GNA13 EXOG CAPRIN1	4.59e-05	195	110	7	1575_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; HL60; HG-U133A	SGTA SLC3A2 DHX8 ITFG1 NADSYN1 MCM3AP DMAC2L	4.74e-05	196	110	7	1373_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A	MED18 SLC4A7 ZNF280D ETS2 NSD1 ACTN4 DMAC2L	4.90e-05	197	110	7	3433_DN
Drug	THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A	MED18 SGTA NBEA SLC3A2 SCYL2 VPS13D ZFHX3	5.05e-05	198	110	7	7266_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; PC3; HG-U133A	HIVEP1 PHF8 CREBBP EVI5 VPS13D UBR5 ATP2B1	5.22e-05	199	110	7	1901_UP
Disease	Intellectual Disability	NSD1 POU3F3 NBEA TFG SLC1A2 ERLIN2 NF1 MACF1 USP27X	3.48e-05	447	106	9	C3714756
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1F CACNA1S	7.63e-05	4	106	2	DOID:0060173 (implicated_via_orthology)
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B1 ATP2B2	1.90e-04	6	106	2	DOID:0050429 (implicated_via_orthology)
Disease	Nerve Degeneration	ETS2 SLC1A2 ERLIN2 PANK2	2.32e-04	83	106	4	C0027746
Disease	acute myeloid leukemia (is_implicated_in)	NSD1 CREBBP NF1 DLEC1	2.43e-04	84	106	4	DOID:9119 (is_implicated_in)
Disease	migraine disorder	NSD1 NBEA ACTN4 SSBP2 SVIL MACF1 ATP2B1	3.13e-04	357	106	7	MONDO_0005277
Disease	CMRF35-like molecule 6 measurement	GPRC5C ATP2B1	3.53e-04	8	106	2	EFO_0008086
Disease	lung non-small cell carcinoma (is_marker_for)	PECAM1 SLC3A2 NF1 UBR5 ZFHX3	3.69e-04	169	106	5	DOID:3908 (is_marker_for)
Disease	Leukemia, Myelocytic, Acute	NSD1 GPR183 CREBBP NF1 SVIL	4.11e-04	173	106	5	C0023467
Disease	pulse pressure measurement	SOX6 SLC4A7 PECAM1 CKAP5 TNRC6B NBEA ACTN4 DHX8 EBF2 ZFHX3 DLEC1 PBX3 ATP2B1 SCAI	4.62e-04	1392	106	14	EFO_0005763
Disease	high grade glioma (is_implicated_in)	SOX6 NADSYN1 NF1	4.67e-04	42	106	3	DOID:3070 (is_implicated_in)
Disease	neuroblastoma (is_implicated_in)	PECAM1 NSD1	5.65e-04	10	106	2	DOID:769 (is_implicated_in)
Disease	systolic blood pressure, alcohol consumption measurement	SOX6 SLC4A7 ATP2B1	6.51e-04	47	106	3	EFO_0006335, EFO_0007878
Disease	guanosine diphosphate measurement	NBEA TBC1D4	6.88e-04	11	106	2	EFO_0010494
Disease	lung adenocarcinoma (is_implicated_in)	LRP1B UBR5 ZFHX3	7.36e-04	49	106	3	DOID:3910 (is_implicated_in)
Disease	phenylacetylglutamine measurement	RBBP8 SCP2	8.24e-04	12	106	2	EFO_0021013
Disease	syndrome (implicated_via_orthology)	NSD1 ZDHHC15	1.88e-03	18	106	2	DOID:225 (implicated_via_orthology)
Disease	mean arterial pressure	SOX6 SLC4A7 EBF2 ARAP3 EFR3B ZFHX3 ATP2B1	2.19e-03	499	106	7	EFO_0006340
Disease	autism spectrum disorder (implicated_via_orthology)	ZNF280D NBEA CREBBP CNTNAP4	2.24e-03	152	106	4	DOID:0060041 (implicated_via_orthology)
Disease	Drugs used in diabetes use measurement	NSD1 NF1 TLE1 MACF1 ZFHX3	2.31e-03	255	106	5	EFO_0009924
Disease	Autistic Disorder	PECAM1 NSD1 NBEA ZNF713 NF1	2.56e-03	261	106	5	C0004352
Disease	Pseudoaphakia	TDRD7 ATP2B1	3.35e-03	24	106	2	C0524524
Disease	Lens Opacities	TDRD7 ATP2B1	3.35e-03	24	106	2	C1510497

Protein segments in the cluster

Peptide	Gene	Start	Entry
MGDNPFQPKSNSKMA	ZNF280D	1	Q6N043
AMMANAAQKFPFNTP	ASNS	496	P08243
MFFPMKSSQGSVEEQ	ARAP3	1381	Q8WWN8
DNQFSMNGDCVMDKP	RBBP8	476	Q99708
PMGDNTKSQLAMSAN	BPIFB4	411	P59827
VNKMMQTNVPGVFAA	AIFM3	451	Q96NN9
NMPQMSFQETKDLGR	APOBEC4	321	Q8WW27
KSEVSPGMAFSNMTN	ARHGEF5	916	Q12774
AFMPSEGKMVSDINN	ACTN4	371	O43707
QPNSANMASLSAMGK	CREBBP	106	Q92793
AMGNVSFSCSQPQSM	CNTNAP4	356	Q9C0A0
SNSMNGYSNVPMANL	EBF2	476	Q9HAK2
FNMAEIMQKNSNRSP	DNAH11	4266	Q96DT5
NAQNPSGETAFKAMM	ABHD4	246	Q8TB40
MPENQSATKELGQMN	CCDC144CP	171	Q8IYA2
TCADQMMPFGKISQQ	DMAC2L	11	Q99766
APFQSMQTVFNMNAP	CAPRIN1	511	Q14444
NKAKAQDGAAMEMQP	ATP2B1	321	P20020
QDGAAAMEMQPLKSA	ATP2B2	351	Q01814
MVKAVVLDPSNGFNM	CFAP206	36	Q8IYR0
MISQADDLSNPFGQM	R3HDM2	431	Q9Y2K5
AAMANNLQKGSAGPM	RBM39	236	Q14498
LAEQSTGMAAQAPKM	NSD1	2236	Q96L73
SKANFSIGPMMQDLA	KIR2DS2	81	P43631
MLFDKNGNMAGISDQ	SERPIND1	416	P05546
FCDSPGQMMKNSVDS	KIAA1107	251	Q9UPP5
MNMPLNSDGTVTFNA	CACNA1F	1511	O60840
SFNLPNSGDMFMNMQ	PBX3	341	P40426
SKANFSIGPMMQDLA	KIR2DL2	81	P43627
MPAKSFNQCVAVMDG	KLHL31	351	Q9H511
FSNMGNPMNTTQLGK	NFKBIZ	401	Q9BYH8
NMANMDGSNSKILFQ	LRP1B	1716	Q9NZR2
SKANFSIGPMMQDLA	KIR2DL3	81	P43628
KSFNMMSPTGDNSEL	ESPN	641	B1AK53
PMSSFDAKINNENMT	MCM3AP	766	O60318
QNPGTEFTNKNMLMT	CYP2S1	281	Q96SQ9
QPGASSSQDQGMFLM	OR2W3	261	Q7Z3T1
NSNNEKMSDPNMEAN	PECAM1	646	P16284
GFQCNNMMSALPSNF	EFR3B	441	Q9Y2G0
MNDFGIKNMDQVAPV	ETS2	1	P15036
MVTNKMTAAFRNPSG	EVI5	1	O60447
ASVGNPEGAFMKMLQ	LRRC37B	751	Q96QE4
MAPAGNNKFSSKAMA	EXOG	141	Q9Y2C4
GDNSNQQHGDKMMSF	GNA13	111	Q14344
ANVSVMDGKMQPNSF	OSBPL6	211	Q9BZF3
FMENKSRMLASGNQP	MACF1	4236	Q9UPN3
IPNMFMDSAGSVSKQ	ERLIN2	301	O94905
PAGQDMVSDDMKNFA	MED18	176	Q9BUE0
QKGQSMFVENKAFSM	GPRC5C	331	Q9NQ84
DMPAFIQMGRDKNFS	PANK2	291	Q9BZ23
GNMDSFMAQVKSLAQ	NOTUM	61	Q6P988
SSNANMLRKGPAEDM	CKAP5	1446	Q14008
MNMPLNSDGTVTFNA	CACNA1S	1451	Q13698
MVKTCNSEESGNFPM	GAS2L3	91	Q86XJ1
MASTEGANNMPKQVE	SLC1A2	1	P43004
QDMGNTQDMFSPDQS	BCL9L	861	Q86UU0
MPENQSATKELGQMN	CCDC144B	171	Q3MJ40
EKQPMNAASGAAMSL	SLC3A2	121	P08195
MNPKVQQNMFSGSED	KIAA1210	991	Q9ULL0
FMGAKGNTAAQMSQA	HMSD	11	A8MTL9
ASAAMFMVKNGNGTA	LAMP1	26	P11279
FMVKNGNGTACIMAN	LAMP1	31	P11279
SGSPKMSNIMQSIAN	EMSY	236	Q7Z589
MPENQSATKELGQMN	CCDC144A	171	A2RUR9
MLMGQQEPAKAAVAF	DLEC1	1671	Q9Y238
DPSSVKMVQSDFMQG	POU3F3	66	P20264
GSKFDNIGMNAMANK	CEBPZ	991	Q03701
NIGMNAMANKDNASL	CEBPZ	996	Q03701
KNPDGSLSQAAMMQS	DHX8	466	Q14562
MTPENFTSCGFMQQI	SERPINB2	71	P05120
QMINPSVGTAVMNFK	MS4A12	71	Q9NXJ0
QMSPQAAANGSLSIM	IGF2R	1156	P11717
SGDMDSISKNSPNNM	SSBP2	311	P81877
MNFMRKIPTGAEASN	SLC4A7	416	Q9Y6M7
FKGGDMSKNVSQSQM	SRP54	441	P61011
NNPGFMSMASNLMNN	SGTA	226	O43765
KEFSMAKMNAQGNLD	SVIL	1016	O95425
MNFGAFSINPAMMAA	TARDBP	311	Q13148
FSINPAMMAAAQAAL	TARDBP	316	Q13148
PKSNMESFNTFANRM	TAF1A	111	Q15573
MANRTSVMFNFPDQA	NBEA	2231	Q8NFP9
ANDSTSAMPEQMKFQ	PRSS23	206	O95084
MDIQMANNFTPPSAT	GPR183	1	P32249
SEEAAMMSSQAQGPQ	PHF12	906	Q96QT6
NMGFQTSGFNMPVNT	SCYL2	776	Q6P3W7
NMPMSGNTGENFRKN	TDRD7	866	Q8NHU6
DSDFLALMTGKMNPQ	SCP2	501	P22307
ALMTGKMNPQSAFFQ	SCP2	506	P22307
QMFSDMVLKDGFQPS	TFRC	431	P02786
AAQLASMQVSPGAKM	SOX6	371	P35712
LQMGTNKFASQQGMT	CNN1	166	P51911
NMSPQMSAAAAAAAV	TLE1	396	Q04724
TPFMASSKESRMNGQ	USP27X	336	A6NNY8
MKPSQSFMTSQLDAN	PLEKHD1	451	A6NEE1
MAASMSAFDPLKNQD	TFG	161	Q92734
SMSLDMGQPSQANTK	NF1	2521	P21359
LASQMNKPGMQESAD	SCAI	311	Q8N9R8
MGDAKTTQPNSMESN	TRAV26-2	16	A0A0B4J265
ASPMNKSPSAMQQQD	TBC1D4	781	O60343
SSGMKPGQFNDCQNM	ZNF717	151	Q9BY31
PSAMAALAAEMNFFQ	ZNF821	371	O75541
AFGMAQANRSTTPMA	PHF8	996	Q9UPP1
MPSQNAVFSQEGNME	ZNF713	1	Q8N859
PVGFQSNNIAMAKGM	XPNPEP2	536	O43895
QFEMAMSNIKPDKAN	VAV2	506	P52735
MENEPQFSAIMQAFG	XPO6	971	Q96QU8
EKPQNMMVVGQSAFA	ITFG1	251	Q8TB96
MSAAQKNEQGAMQSA	HIVEP1	266	P15822
MMSQNKGNVVKFSAG	ZBBX	81	A8MT70
KAQAFERMMSPTGSN	ZFYVE16	806	Q7Z3T8
NAPNAMKPNSKSMQD	TNRC6B	981	Q9UPQ9
DSWMNPLAKQFSNMG	TNRC6B	1056	Q9UPQ9
QAMQPAFASKITGML	UBR5	2406	O95071
DGHSFPMRSMNESQN	ZDHHC15	291	Q96MV8
ASDAQFMMSGFQLDP	ZFHX3	881	Q15911
FSNQAESMMVPGNAA	UNC79	2061	Q9P2D8
GTPQMNESAFMQLEF	VPS13D	516	Q5THJ4
AMIAMNGSVFAQGSQ	NADSYN1	246	Q6IA69